Melexis 将来の成長

ENXTBR:MELE - アナリストの将来予測と過去の財務データ ( )EUR Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	1,044	205	164	224	11
12/31/2025	932	166	146	201	11
12/31/2024	941	182	168	237	9
9/30/2024	986	203	101	169	N/A
6/30/2024	987	209	70	153	N/A
3/31/2024	978	211	-91	3	N/A
12/31/2023	964	209	-92	3	N/A
9/30/2023	938	212	-74	7	N/A
6/30/2023	909	204	-21	42	N/A
3/31/2023	881	199	132	184	N/A
12/31/2022	836	197	148	188	N/A
9/30/2022	779	178	158	194	N/A
6/30/2022	722	166	124	161	N/A
3/31/2022	672	152	105	140	N/A
12/31/2021	644	131	103	142	N/A
9/30/2021	625	122	95	132	N/A
6/30/2021	584	100	92	123	N/A
3/31/2021	525	76	80	109	N/A
12/31/2020	508	69	71	96	N/A
9/30/2020	487	61	72	95	N/A
6/30/2020	489	61	81	104	N/A
3/31/2020	509	67	75	101	N/A
12/31/2019	487	60	68	94	N/A
9/30/2019	501	73	67	105	N/A
6/30/2019	525	88	45	96	N/A
3/31/2019	547	101	35	98	N/A
12/31/2018	569	115	23	100	N/A
9/30/2018	560	114	5	78	N/A
6/30/2018	541	112	N/A	89	N/A
3/31/2018	527	114	N/A	106	N/A
12/31/2017	512	111	N/A	113	N/A
9/30/2017	499	109	N/A	116	N/A
6/30/2017	486	107	N/A	96	N/A
3/31/2017	470	99	N/A	108	N/A
12/31/2016	456	96	N/A	108	N/A
9/30/2016	439	93	N/A	116	N/A
6/30/2016	426	93	N/A	134	N/A
3/31/2016	415	95	N/A	127	N/A
12/31/2015	400	99	N/A	115	N/A
9/30/2015	386	97	N/A	109	N/A
6/30/2015	371	97	N/A	103	N/A
3/31/2015	351	93	N/A	97	N/A
12/31/2014	332	85	N/A	95	N/A
9/30/2014	319	81	N/A	95	N/A
6/30/2014	304	71	N/A	84	N/A
3/31/2014	289	63	N/A	80	N/A
12/31/2013	275	55	N/A	71	N/A

アナリストによる今後の成長予測

収入対貯蓄率: MELEの予測収益成長率 (年間5.5% ) は貯蓄率 ( 1.4% ) を上回っています。

収益対市場: MELEの収益 ( 5.5% ) Belgian市場 ( 19.8% ) よりも低い成長が予測されています。

高成長収益: MELEの収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: MELEの収益 ( 5.6% ) Belgian市場 ( 7.1% ) よりも低い成長が予測されています。

高い収益成長: MELEの収益 ( 5.6% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: MELEの自己資本利益率は、3年後には高くなると予測されています ( 36.3 %)

Melexis 将来の成長

Future 基準チェック /26

主要情報

今後の成長に関する最新情報

Price target decreased by 10% to €77.55

Price target decreased by 7.3% to €83.56

Earnings Update: Melexis NV (EBR:MELE) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts

Price target increased by 9.4% to €91.57

Melexis Provides Earnings Guidance for the Fourth Quarter and Full Year of 2022

Price target decreased to €82.38

Recent updates

Price target decreased by 10% to €77.55

Price target decreased by 7.3% to €83.56

Third quarter 2024 earnings: Revenues and EPS in line with analyst expectations

These 4 Measures Indicate That Melexis (EBR:MELE) Is Using Debt Reasonably Well

Melexis NV to Report Q3, 2025 Results on Oct 29, 2025

Melexis (EBR:MELE) Is Paying Out A Dividend Of €0.91

First half dividend of €0.91 announced

Should You Think About Buying Melexis NV (EBR:MELE) Now?

Insufficient new directors

Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations

There's Reason For Concern Over Melexis NV's (EBR:MELE) Price

Earnings Update: Melexis NV (EBR:MELE) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts

Second quarter 2024 earnings: EPS misses analyst expectations

A Look At The Fair Value Of Melexis NV (EBR:MELE)

Is There Now An Opportunity In Melexis NV (EBR:MELE)?

Melexis (EBR:MELE) Knows How To Allocate Capital

Melexis (EBR:MELE) Seems To Use Debt Quite Sensibly

Shareholders Will Probably Be Cautious Of Increasing Melexis NV's (EBR:MELE) CEO Compensation At The Moment

Upcoming dividend of €1.68 per share

Investor sentiment improves as stock rises 16%

New minor risk - Share price stability

Full year 2023 earnings: EPS misses analyst expectations

Calculating The Fair Value Of Melexis NV (EBR:MELE)

At €78.60, Is Melexis NV (EBR:MELE) Worth Looking At Closely?

Many Would Be Envious Of Melexis' (EBR:MELE) Excellent Returns On Capital

Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations

Final dividend of €1.68 announced

Full year 2023 earnings: EPS misses analyst expectations

Melexis NV, Annual General Meeting, May 14, 2024

Melexis (EBR:MELE) Has A Pretty Healthy Balance Sheet

What Does Melexis NV's (EBR:MELE) Share Price Indicate?

Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors

Melexis (EBR:MELE) Knows How To Allocate Capital

Calculating The Intrinsic Value Of Melexis NV (EBR:MELE)

Now 22% undervalued after recent price drop

Third quarter 2023 earnings: EPS exceeds analyst expectations

Melexis NV to Report Q2, 2024 Results on Jul 31, 2024

Melexis' (EBR:MELE) Dividend Will Be €0.91

Upcoming dividend of €0.91 per share at 4.3% yield

Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91

Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?

Melexis (EBR:MELE) Has Announced A Dividend Of €0.91

Melexis (EBR:MELE) Has Announced A Dividend Of €0.91

Melexis' (EBR:MELE) Dividend Will Be €0.91

New major risk - Earnings quality

Second quarter 2023 earnings: EPS exceeds analyst expectations

Melexis (EBR:MELE) Might Become A Compounding Machine

Do Melexis' (EBR:MELE) Earnings Warrant Your Attention?

Estimating The Intrinsic Value Of Melexis NV (EBR:MELE)

Upcoming dividend of €1.54 per share at 5.0% yield

At €99.75, Is Melexis NV (EBR:MELE) Worth Looking At Closely?

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

With EPS Growth And More, Melexis (EBR:MELE) Makes An Interesting Case

Price target increased by 9.4% to €91.57

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

Melexis NV, Annual General Meeting, May 09, 2023

Is It Time To Consider Buying Melexis NV (EBR:MELE)?

Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors

Is Melexis NV (EBR:MELE) Expensive For A Reason? A Look At Its Intrinsic Value

Investor sentiment improved over the past week

Melexis NV to Report Q2, 2023 Results on Aug 02, 2023

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Melexis Provides Earnings Guidance for the Fourth Quarter and Full Year of 2022

Melexis (EBR:MELE) Is Paying Out A Dividend Of €0.91

Upcoming dividend of €0.91 per share

Melexis' (EBR:MELE) Dividend Will Be €0.91

Now 23% undervalued

Melexis' (EBR:MELE) Dividend Will Be €0.91

We Ran A Stock Scan For Earnings Growth And Melexis (EBR:MELE) Passed With Ease